These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8267510)
41. [Radiofrequency catheter ablation of ventricular tachycardia in patients with an implantable defibrillator. Long-term follow-up]. Cabrera AM; Cordero AB; Rodríguez JA; Carmona JR; de Teresa Galván E Rev Esp Cardiol; 2005 May; 58(5):491-8. PubMed ID: 15899194 [TBL] [Abstract][Full Text] [Related]
42. [Endocardial mapping and high frequency catheter ablation of ventricular tachycardia after myocardial infarction]. Willems S; Weiss C; Meinertz T Z Kardiol; 2000; 89 Suppl 3():161-70. PubMed ID: 10810799 [TBL] [Abstract][Full Text] [Related]
43. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators. Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458 [TBL] [Abstract][Full Text] [Related]
44. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097 [TBL] [Abstract][Full Text] [Related]
45. Treatment of ventricular arrhythmias in the elderly. Aronow WS Cardiol Rev; 2009; 17(3):136-46. PubMed ID: 19384088 [TBL] [Abstract][Full Text] [Related]
46. Implantable cardioverter-defibrillator: present and future indications. Block M; Scheld H; Breithardt G Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176 [TBL] [Abstract][Full Text] [Related]
47. How to avoid inappropriate therapy. Israel CW Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830 [TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of ventricular tachycardia. Indications and results. Pagé PL Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():115-21. PubMed ID: 8734172 [TBL] [Abstract][Full Text] [Related]
49. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827 [TBL] [Abstract][Full Text] [Related]
51. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Hsia HH; Callans DJ; Marchlinski FE Circulation; 2003 Aug; 108(6):704-10. PubMed ID: 12885746 [TBL] [Abstract][Full Text] [Related]
52. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia]. Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168 [TBL] [Abstract][Full Text] [Related]
53. [Anesthesia and surveillance in intracavitary fulguration for radical treatment of ventricular tachycardia]. Gallais Y; Touzet M; Gateau O; Maneglia R; Frank R; Fontaine G; Cousin MT Ann Cardiol Angeiol (Paris); 1986 Nov; 35(9):539-50. PubMed ID: 3813460 [TBL] [Abstract][Full Text] [Related]
54. [Quality assurance in interventional electrophysiology (ablation, automatic defibrillators)]. Breithardt G; Hindricks G; Borggrefe M; Block M Z Kardiol; 1994; 83 Suppl 6():69-74. PubMed ID: 7863703 [TBL] [Abstract][Full Text] [Related]
55. [Successful VT ablation in a patient with ventricular assist device and implantable cardiac defibrillator]. Islamoğlu Y; Aktaş MK; Cil H; Arıtürk Z; Tekbaş E; Elbey MA Anadolu Kardiyol Derg; 2011 Dec; 11(8):740-1. PubMed ID: 22137944 [No Abstract] [Full Text] [Related]
56. Arrhythmic storm solved with ExtraCorporeal Membrane Oxygenation and consecutive percutaneous coronary intervention and ventricular tachycardia ablation. Sousa-Casasnovas I; Ávila-Alonso P; Juárez-Fernández M; Díez-Delhoyo F; Martínez-Sellés M; Fernández-Avilés F Med Intensiva (Engl Ed); 2018 Nov; 42(8):504-506. PubMed ID: 28662908 [No Abstract] [Full Text] [Related]
57. [Implantable automatic defibrillators in the treatment of ventricular tachycardia]. Leenhardt A; Thomas O; Coumel P Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():27-32. PubMed ID: 9749282 [TBL] [Abstract][Full Text] [Related]
58. VT reduction with ablation: A transitive relation to mortality rate? Deyell MW; Cooper JM Heart Rhythm; 2015 Sep; 12(9):2008-9. PubMed ID: 26164376 [No Abstract] [Full Text] [Related]
59. Ablation therapy of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and primary electrical diseases: new insights in invasive treatment options in severely symptomatic patients. Monaco C; Sorgente A; Ramak R; Chierchia GB; La Meir M; de Asmundis C Herzschrittmacherther Elektrophysiol; 2021 Sep; 32(3):323-329. PubMed ID: 34228177 [TBL] [Abstract][Full Text] [Related]
60. Ablation of ventricular tachycardia in 2021. Bianchi S; Cauti FM Eur Heart J Suppl; 2021 Oct; 23(Suppl E):E25-E27. PubMed ID: 35233211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]